Callodine Specialty Income Fund
Share Class NAV
$25.42
As of 03/06/2025

Fund Overview

 

Callodine Specialty Income Fund (“CSIF“ or the “Fund”) is an unlisted closed-end management investment company that is structured as an interval fund. CSIF seeks to produce high current income by investing directly or indirectly in primarily a range of private corporate, real estate and alternative credit opportunities. At its core, the Fund’s strategic asset mix is designed to generate yield, optimize liquidity management and mitigate volatility.

Fund Facts

 
Class I Ticker
CALIX
Fund Inception Date
Jan 01, 2022
Total Managed Assets1
$xxx.x mm
Net Asset Value (NAV)2
$25.42
Target Distribution Rate3
8% annually of the Fund’s NAV per share
Distribution Frequency4
Quarterly
Subscriptions
Daily
Liquidity5
Quarterly
Tax Reporting
Form 1099-DIV
Accreditation Requirement
None

Potential Benefits

 
MULTI-STRATEGY PRIVATE  CREDIT EXPOSURE

MULTI-STRATEGY PRIVATE CREDIT EXPOSURE

Focused primarily on various
middle market private credit
investment strategies
SPECIALIZED INVESTMENT TEAMS

SPECIALIZED INVESTMENT TEAMS

Dedicated and highly
experienced investment
teams within each vertical
TACTICAL & DYNAMIC ASSET ALLOCATION

TACTICAL & DYNAMIC ASSET ALLOCATION

Seeks to blend income-
oriented asset classes that
may be less correlated with
one another and provide
different drivers of return
INVESTOR FRIENDLY STRUCTURE

INVESTOR FRIENDLY STRUCTURE

Interval fund structure offers 
access to private credit
strategies that have
historically been only available
to institutional investors

Allocations, unless otherwise indicated, are based on the total portfolio and subject to change without notice. Data shown is for informational purposes only and not a recommendation to buy or sell any security.

Performance data quoted represents past performance and is no guarantee of future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted. Performance shown is net of fees and reflects the reinvestment of dividends. Performance would have been lower without expense limitations currently in effect. Short term performance in particular is not a good indication of the fund’s future performance and an investment should not be made based solely on returns.

Our Team

 

Callodine Specialty Income Fund is a multi-strategy interval fund that invests in both private credit and public, income-oriented assets through Callodine’s specialized investment teams. James Morrow & Gene Martin serve as Co-Portfolio Managers for the Fund and are supported by highly experienced investment professionals and their respective teams across asset-based lending, real estate lending, direct lending, life sciences finance, high yield debt, and yielding equity securities.

Yielding Equity Securities

James Morrow

Chief Investment Officer
Callodine Capital Management
Asset Based Lending

Gene Martin

President & CEO
Callodine Credit Management
Real Estate Lending

Kevin Miller

Principal & CEO
Thorofare Capital
Real Estate Lending

Brendan Miller

Principal & CIO
Thorofare Capital
Direct Lending

Scott Barfield

Co-CEO
Rand Capital Management
Direct Lending

Steve Brannon

Managing Director
Rand Capital Management
Life Sciences Finance

Winston Black

Head of Life Sciences Finance
Rand Capital Management
High Yield Debt

Marc Bushallow

Managing Director of Fixed Income
Manning & Napier

Literature

 

Ready To Invest

 

 
The Callodine Specialty Income Fund is only available through participating Broker/Dealers and Registered Investment Advisors. If you are interested in learning whether alternative investments are suitable for your investment needs, please contact your investment professional.
LOOKING FOR AN
INVESTMENT PROFESSIONAL?
Learn More

Summary of Risk Factors

 

An investment in the Fund involves a high degree of risk, is considered speculative and illiquid, and is not suitable for all investors. No guarantee or representation is made that the Fund’s investment program, including, without limitation, its investment objectives, will be successful. Investors should consider the Fund as a supplement to an overall Investment program and should invest only if they are willing to undertake the risks involved, including the possible loss of all or a substantial portion of their investment. Below is a summary of some of the principal risks of investing in the Fund. For a more complete discussion of the risks of investing in the Fund, see " Principal Risk Factors" in the prospectus. Shareholders should consider carefully the following principal risks before investing in the Fund.

  • Unlike most closed-end funds, the Fund's Shares will not be listed on any securities exchange;
  • Although the Fund is required to, and has implemented a Share repurchase program, only a limited number of shares will be eligible for repurchase by the Fund. You should consider that you may not have access to the money you invest for an indefinite period of time;
  • The Fund may be materially adversely affected by market, economic and political conditions globally and in the jurisdictions and sectors in which the Fund invests;
  • The Fund's investments in securities and other obligations of companies that are experiencing distress involve a substantial degree of risk, require a high level of analytical sophistication for successful investment, and require active monitoring;
  • The Fund will invest a portion of its assets in debt and debt-related securities, which include unsecured loans. All debt or debt related securities are exposed to credit risk, including default risk. The Fund is exposed to risks associated with changes in interest rates. There is an inverse relationship between bond prices and interest rates; as interest rates rise, bond prices (and therefore the value of bond funds) fall. Likewise, as interest rates fall, bond prices and the value of bond funds rise;
  • Most of the credit instruments in which the Fund invests will be rated below investment grade by rating agencies, and many will have no credit rating at all. Credit instruments that are rated below investment grade (i.e., “high yield” securities or “junk bonds”) involve additional risks, including higher risk of default and loss of principal;
  • A significant portion of the Fund’s investments may be originated. The results of the Fund’s operations depend on several factors, including the availability of opportunities for the origination or acquisition of target investments, the level and volatility of interest rates, the availability of adequate short and long-term financing, conditions in the financial markets and economic conditions. Fund investments in non-performing and sub-performing loans may be subject to additional bankruptcy related risks and returns on such investments may not be realized for a considerable period of time. The Fund’s performance with respect to real estate lending will depend on the ability of its borrowers to repay their loans. In turn, the Fund’s borrowers are subject to local, regional, and national real estate market and economic conditions beyond their control and beyond the control of the Fund. Fund investments in asset-backed securities may have a structure that makes their reaction to interest rate changes and other factors difficult to predict, making their value highly volatile. In addition, the underlying assets are subject to prepayments that shorten the securities’ weighted average maturity and may lower their return;
  • The Fund's investments in preferred and convertible securities are subject to interest rate risk and credit risk, similar to fixed income securities, as well as equity market risk;
  • The assets in the Life Sciences Finance segment are expected to be royalty streams or debt backed by royalty streams or revenue interests paid by small and middle-market life sciences businesses, which are highly speculative and involve a high degree of risk of credit loss;
  • The valuation of securities or instruments that lack a central trading place (such as fixed-income securities or instruments) may carry greater risk than those that trade on an exchange;
  • The Fund may invest a portion of its assets in real estate investment trusts (REITs), which are subject to risks associated with the direct ownership of real estate; interest rate risk, liquidity risk, and changes in property value, among others. The Fund may also invest a portion of its assets in business development companies (BDCs) or master limited partnerships (MLPs). BDCs are subject to additional risks, as they generally invest in less mature private companies or thinly traded U.S. public companies which involve greater risk than well-established publicly traded companies. MLPs are subject to additional risks associated with the specific industry or industries in which the partnership invests as the MLP will be negatively impacted by economic events adversely impacting that industry. Additionally, the potential tax benefits from investing in MLPs depends on their continued treatment as partnerships for federal income tax purposes;
  • Investment in private and small or middle-market companies involves a number of significant risks as there is generally little public information available about these companies. Such companies typically have shorter operating histories, narrower product lines and smaller market shares than larger businesses, which tend to render them more vulnerable to competitors’ actions and market conditions, as well as general economic downturns;
  • Investments in foreign countries may be subject to the risks of adverse changes in foreign economic, political, regulatory, and other conditions as well as the risks related to the use of different financial standards;
  • Fund performance is dependent upon the success of the Investment Adviser and the Sub-Advisers in implementing the Fund’s investment strategies in pursuit of its investment objective. The Investment Adviser will be dependent on information provided by the Sub-Advisers, which if inaccurate could adversely affect the Investment Adviser’s ability to manage the Fund’s investment portfolio in accordance with its investment objective;
  • The Fund operates in a highly competitive market for investment opportunities. The Fund's financial condition and results of operations could be negatively affected if a significant investment fails to perform as expected. There are potential conflicts of interest relating to co-investing that could impact the Fund's investment returns;
  • The Fund's ability to grow depends on its ability to raise capital. The Fund may borrow money, which magnifies the potential for gain or loss on amounts invested, subjects the Fund to certain covenants with which it must comply and may increase the risk of investing with the Fund;
  • The Fund is non-diversified, which means that it may invest in the securities of relatively few issuers. Additionally, the Fund may at times invest more heavily in a particular sector. As a result, the Fund may be more susceptible to adverse economic or political occurrence affecting one or more of these issues or sectors and, therefore, may experience increased volatility;
  • To qualify and remain eligible for the special tax treatment accorded to Registered Investment Companies (RICs) and their shareholders under the Code, the Fund must meet certain source-of-income, asset diversification and annual distribution requirements, and failure to do so could result in the loss of RIC status;
  • The Fund is a newly organized investment company with no operating or performance history investors can use to evaluate it.

Disclosures

 

1As of xx/xx/xxxx
2As of xx/xx/xxxx
3Target Distribution Rate is not guaranteed and may be modified by the Board from time to time.
4The Fund intends to make regular quarterly distributions to its shareholders of substantially all of its income, commencing in the first full quarter of the Fund’s operations.
5The amount of distributions that the Fund may pay, if any, is uncertain. The Fund may pay distributions in significant part from sources that may not be available in the future and that are unrelated to the Fund’s performance, such as from offering proceeds, borrowings, and amounts from the Fund’s affiliates that are subject to repayment by investors.

Before investing you should carefully consider the Fund's investment objectives, risks, charges and expenses. This and other information is in the prospectus, a copy of which may be obtained from the Fund at [insert toll-free number]. An investor should read the prospectus carefully before investing.

An investment in the Fund involves a high degree of risk, is considered speculative and illiquid, and is not suitable for all investors. There can be no assurance that the Fund’s investment objective will be achieved or that its investment program will be successful. Investors could lose some or all of their investment. No public market for Shares exists, and none is expected to develop in the future. Investors should generally not expect to be able to sell their Shares (other than through the limited repurchase process), regardless of how the Fund performs. Investors should consider the Fund as a supplement to an overall Investment program and should invest only if they are willing to undertake the risks involved, including risks that are inherent in securities investments generally as well as those risks that are specific to an investment in the Fund.

This information has been prepared by Callodine Capital Management, LP ("Callodine"), a registered investment adviser and adviser to the Callodine Specialty Income Fund (the "Fund"). Distribution Services, LLC (the "Distributor") acts as the principal underwriter of the Fund’s shares which is not affiliated with Callodine Capital Management, LP or any of their affiliates. Manning & Napier Investor Services, Inc. ("MNBD"), an affiliate of Callodine has a selling agreement in place to sell the Fund. This is neither an offer to sell nor a solicitation to purchase the securities described herein. Such an offering is made only by means of prospectus. Please read the prospectus prior to making any investment decisions and consider the risks, charges, expenses and other important information described therein. A copy of the prospectus must be made available to you in connection with any offering. Click here to view prospectus.

The information in this website may contain projections or other forward-looking statements regarding future events, targets, forecasts or expectations regarding the strategies described herein, and is only current as of the date indicated. There is no assurance that such events or targets will be achieved, and actual results may be significantly different from those shown here. The information set forth is subject to change without notice, including, without limitation, the terms of the Fund and any portfolio construction targets set forth herein, as well as market conditions and events. The views expressed reflect the current views of Callodine as of the date hereof and Callodine does not undertake to advise you of any changes in the views expressed herein.